Although the number of clinical studies correlating ERα phosphorylation and patient prognosis/outcome are relatively few, these studies present the possibility that ERα phosphorylation could be predictive of responsiveness to endocrine therapy in ERα positive breast cancer. Here, ESR1 is linked to breast carcinoma.